FDA Rejects Nuplazid Application for Treatment of Alzheimer’s Disease Psychosis
The agency said more clinical trials would be required showing clearer results before it could approve Nuplazid to treat Alzheimer's disease psychosis.
The agency said more clinical trials would be required showing clearer results before it could approve Nuplazid to treat Alzheimer's disease psychosis.